TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 10468689

Group type: EXPERIMENTAL
Intervention: EC‐ASA 100 mg/day
Number of subjects: 59

Group type: COMPARATOR
Intervention: Plain ASA 100 mg/day
Number of subjects: 59

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 59
Study: 8707779

Group type: EXPERIMENTAL
Intervention: Wee Wheezers asthma education program
Number of subjects: 76
Study: 1836097

Group type: EXPERIMENTAL
Intervention: Low-dose intravenous nitroglycerin infusion
Number of subjects: 310
Study: 7201725

Group type: EXPERIMENTAL
Intervention: Tetravalent (1, 3, 4, 12F) polysaccharide pneumococcal vaccine
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Tetravalent (14, 18C, 19F, 23F) vaccine
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Pentadecavalent vaccine (1, 3, 4, 6A, 7F, 8, 9N, 11A, 12F, 14, 15F, 18C, 19F, 23F)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 68
Study: 30815861

Group type: EXPERIMENTAL
Intervention: Attachment and Biobehavioral Catch-up (ABC)
Number of subjects: 101

Group type: COMPARATOR
Intervention: Control intervention
Number of subjects: 101
Study: 31310993

Group type: EXPERIMENTAL
Intervention: Wii Fit Plus® intervention
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 24
Study: 28622623

Group type: EXPERIMENTAL
Intervention: Momelotinib 200mg
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Momelotinib 100mg and 200mg
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Momelotinib
Number of subjects: 39
Study: 27362239

Group type: EXPERIMENTAL
Intervention: Single IUI (n = 290)
Number of subjects: 580

Group type: EXPERIMENTAL
Intervention: Double IUI (n = 290)
Number of subjects: 580

Group type: COMPARATOR
Intervention: Comparison between Single and Double IUI
Number of subjects: 580
Study: 25176414

Group type: EXPERIMENTAL
Intervention: Box trainer training (1 hour per week for 4 weeks)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 22
Study: 21894446

Group type: EXPERIMENTAL
Intervention: Mediterranean diet (MedDiet)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Saturated fatty acid diet (SFA)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Low‐fat and high‐carbohydrate diet (CHO‐ALA)
Number of subjects: 20
Study: 19581537

Group type: COMPARATOR
Intervention: GEM (standard treatment) 1,000 mg/m(2)/30 minutes
Number of subjects: 832

Group type: EXPERIMENTAL
Intervention: GEM FDR 1,500 mg/m(2)/150 minutes
Number of subjects: 832

Group type: EXPERIMENTAL
Intervention: GEMOX (GEM 1,000 mg/m(2)/100 minutes + oxaliplatin 100 mg/m(2)/day 2 every 14 days)
Number of subjects: 832
Study: 17121785

Group type: EXPERIMENTAL
Intervention: 1.36% glucose
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 1.1% amino acid solution
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 3.86% glucose (conventional and biocompatible fluids)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 3.86% glucose
Number of subjects: 10
Study: 16312170

Group type: EXPERIMENTAL
Intervention: Segmental allergen challenge
Number of subjects: 9
Study: 11996957

Group type: EXPERIMENTAL
Intervention: Pitavastatin 2 mg daily
Number of subjects: 240

Group type: COMPARATOR
Intervention: Pravastatin 10 mg daily
Number of subjects: 240
Study: 9583841

Group type: EXPERIMENTAL
Intervention: Usual diet (UD) with 1.2‐1.5 g protein/kg body wt
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Chicken diet (CD) with 1.2‐1.5 g protein/kg body wt
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Low-protein diet (LPD) with 0.5‐0.8 g protein/kg body wt
Number of subjects: 15
Study: 7539186

Group type: EXPERIMENTAL
Intervention: TURP (Transurethral Resection of the Prostate)
Number of subjects: 0

Group type: COMPARATOR
Intervention: VLAP (Visual Laser Ablation of the Prostate)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Laser therapy (holmium and diode lasers)
Number of subjects: 0
Study: 1509068

Group type: EXPERIMENTAL
Intervention: Compressed collagen foam plug placement
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group (no plug)
Number of subjects: 50
Study: 6732159

Group type: EXPERIMENTAL
Intervention: Cimetidine treatment (34 patients)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Control group (18 patients)
Number of subjects: 52
Study: 30912409

Group type: EXPERIMENTAL
Intervention: Probiotic (Pearls IC©)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study: 29371061

Group type: EXPERIMENTAL
Intervention: Theory-based lifestyle intervention (two in-depth counseling sessions, telephone counseling, behavioral podcasts, social media support)
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: Theory-based lifestyle intervention
Number of subjects: 400

Group type: COMPARATOR
Intervention: Standard care (monthly mailings and matched podcasts on non-weight related topics)
Number of subjects: 400

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 400
Study: 26017469

Group type: EXPERIMENTAL
Intervention: On-Pace group (continued pacemaker activity)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Off-Pace group (deactivated pacemaker function)
Number of subjects: 19
Study: 24777973

Group type: EXPERIMENTAL
Intervention: Internet-based cognitive-behavioural intervention
Number of subjects: 72

Group type: COMPARATOR
Intervention: Face-to-face cognitive-behavioural group intervention
Number of subjects: 72
Study: 22412140

Group type: EXPERIMENTAL
Intervention: Salvage chemotherapy (SLC) plus best supportive care (BSC)
Number of subjects: 202

Group type: COMPARATOR
Intervention: Best supportive care (BSC) alone
Number of subjects: 202

Group type: EXPERIMENTAL
Intervention: Salvage chemotherapy (SLC)
Number of subjects: 202
Study: 20151421

Group type: EXPERIMENTAL
Intervention: Sustained-release cytarabine
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Methotrexate
Number of subjects: 100

Group type: COMPARATOR
Intervention: Sustained-release cytarabine (lumbar administration)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Sustained-release cytarabine (ventricular administration)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Methotrexate (lumbar administration)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Methotrexate (ventricular administration)
Number of subjects: 100
Study: 17634781

Group type: EXPERIMENTAL
Intervention: 4-item screen for PTSD
Number of subjects: 398

Group type: EXPERIMENTAL
Intervention: PTSD checklist (PCL-17)
Number of subjects: 398
Study: 15677733

Group type: EXPERIMENTAL
Intervention: Positive airway pressure treatment after a minimum period of 8 weeks
Number of subjects: 16

Group type: COMPARATOR
Intervention: Healthy subjects
Number of subjects: 16
Study: 12062776

Group type: EXPERIMENTAL
Intervention: Dialectical Behavior Therapy (DBT)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Comprehensive Validation Therapy with 12-Step (CVT + 12S)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 23
Study: 9416309

Group type: EXPERIMENTAL
Intervention: Glycerol administration
Number of subjects: 32
Study: 7684524

Group type: EXPERIMENTAL
Intervention: Finasteride 5 mg
Number of subjects: 750

Group type: EXPERIMENTAL
Intervention: Finasteride 1 mg
Number of subjects: 750

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 750
Study: 2879832

Group type: EXPERIMENTAL
Intervention: Clorazepate
Number of subjects: 189

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 189
Study: 29098340

Group type: EXPERIMENTAL
Intervention: Higher levels of alcohol intoxication under easy primary task conditions
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Increasing difficulty of the primary task
Number of subjects: 0

Group type: COMPARATOR
Intervention: Hard primary task conditions
Number of subjects: 0
Study: 27760666

Group type: EXPERIMENTAL
Intervention: Systematic retroperitoneal lymphadenectomy (SL)
Number of subjects: 3353
Study: 25541942

Group type: EXPERIMENTAL
Intervention: Botulinum toxin A
Number of subjects: 60

Group type: COMPARATOR
Intervention: Vehicle (normal saline)
Number of subjects: 60
Study: 22096040

Group type: EXPERIMENTAL
Intervention: High-flux dialysis
Number of subjects: 166

Group type: COMPARATOR
Intervention: Low-flux dialysis
Number of subjects: 166
Study: 20414441

Group type: EXPERIMENTAL
Intervention: Structured educational intervention for pharmacists
Number of subjects: 57

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 57
Study: 17119962

Group type: EXPERIMENTAL
Intervention: Surgical treatment
Number of subjects: 634

Group type: COMPARATOR
Intervention: Non-surgical intervention
Number of subjects: 634
Study: 15990220

Group type: EXPERIMENTAL
Intervention: Solifenacin 5 or 10 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Tolterodine extended release (ER) 4 mg
Number of subjects: 0
Study: 12619955

Group type: EXPERIMENTAL
Intervention: Avoidance of precipitating factors (viral infections, smoke, dust, cold food, cold air)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Short acting beta agonists as needed for mild episodic asthma
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Bronchodilators with daily maintenance treatment (low dose inhaled steroids, cromolyn, oral theophylline, leukotriene antagonists) for mild persistent asthma
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Inhaled steroids with long acting beta agonists for moderate persistent asthma
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Inhaled steroids, long acting beta agonists with or without theophylline for severe persistent asthma
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Oral prednisolone on alternate days if symptoms are not well controlled
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cromolyn, short or long acting beta agonists, or leukotriene antagonists for exercise-induced bronchoconstriction
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Maintenance treatment for children with seasonal asthma starting 2 weeks in advance and continued throughout the season
Number of subjects: 0
Study: 11263278

Group type: EXPERIMENTAL
Intervention: Acupuncture treatment
Number of subjects: 29
Study: 8686404

Group type: EXPERIMENTAL
Intervention: Laparotomy (group A)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Laparoscopy (group B)
Number of subjects: 20
Study: 1578308

Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation (100, 200, or 400 IU/day)
Number of subjects: 256

Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation (400 IU/day recommended)
Number of subjects: 256

Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation (various dosages)
Number of subjects: 256

Group type: COMPARATOR
Intervention: Northern infants
Number of subjects: 256
Study: 3878070

Group type: EXPERIMENTAL
Intervention: Coronary bypass surgery
Number of subjects: 0

Group type: COMPARATOR
Intervention: Medical therapy
Number of subjects: 0
Study: 29548913

Group type: EXPERIMENTAL
Intervention: ZipFix sternal closure (n=168)
Number of subjects: 326

Group type: COMPARATOR
Intervention: Conventional wire sternal closure (n=158)
Number of subjects: 326

Group type: EXPERIMENTAL
Intervention: Overall participants (n=326)
Number of subjects: 326
Study: 30565412

Group type: EXPERIMENTAL
Intervention: Hypoxia training (FiO2 15%)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Normoxia training (FiO2 21%)
Number of subjects: 23
Study: 24955900

Group type: EXPERIMENTAL
Intervention: Cefazolin
Number of subjects: 109

Group type: COMPARATOR
Intervention: Vancomycin
Number of subjects: 109
Study: 21971752

Group type: EXPERIMENTAL
Intervention: Electromyographic biofeedback training
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Electrical stimulation therapy
Number of subjects: 45

Group type: COMPARATOR
Intervention: Home exercise
Number of subjects: 45
Study: 20735271

Group type: EXPERIMENTAL
Intervention: RTS,S/AS01(E) coadministered with EPI vaccines at 0, 1, and 2 months (3 doses)
Number of subjects: 511

Group type: EXPERIMENTAL
Intervention: RTS,S/AS01(E) coadministered with EPI vaccines at 0, 1, and 7 months (2 doses)
Number of subjects: 511

Group type: COMPARATOR
Intervention: EPI vaccines only
Number of subjects: 511
Study: 18834461

Group type: EXPERIMENTAL
Intervention: Atrial synchronous ventricular pacing (VDD)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 12
Study: 11890188

Group type: EXPERIMENTAL
Intervention: Olanzapine
Number of subjects: 2335
Study: 10194773

Group type: EXPERIMENTAL
Intervention: Cisplatin
Number of subjects: 12
Study: 7995745

Group type: EXPERIMENTAL
Intervention: Custom-made hemibody foam cradle (immobilization device)
Number of subjects: 74

Group type: COMPARATOR
Intervention: No immobilization device (control group)
Number of subjects: 74
Study: 2179284

Group type: EXPERIMENTAL
Intervention: metoprolol CR/ZOK 50 mg
Number of subjects: 195

Group type: COMPARATOR
Intervention: atenolol 50 mg
Number of subjects: 195

Group type: EXPERIMENTAL
Intervention: metoprolol CR/ZOK 100 mg
Number of subjects: 195

Group type: COMPARATOR
Intervention: atenolol 100 mg
Number of subjects: 195

Group type: EXPERIMENTAL
Intervention: metoprolol CR/ZOK
Number of subjects: 195

Group type: COMPARATOR
Intervention: atenolol
Number of subjects: 195
Study: 367510

Group type: EXPERIMENTAL
Intervention: Cytotoxic treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Endocrine treatment
Number of subjects: 0
Study: 29489714

Group type: EXPERIMENTAL
Intervention: Combined balance and plyometric training (E) for 8 weeks
Number of subjects: 26

Group type: COMPARATOR
Intervention: Control group (C) maintained normal basketball training schedule
Number of subjects: 26
Study: 31479846

Group type: EXPERIMENTAL
Intervention: Yoga exercise intervention (8 weeks, twice a week instructor-led and once a week home practice)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 40
Study: 27225016

Group type: EXPERIMENTAL
Intervention: Ottawa Model for Smoking Cessation
Number of subjects: 1367
Study: 25854017

Group type: EXPERIMENTAL
Intervention: Prior-to-catheter acupuncture intervention (5 times per week for one month)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Both groups (prior-to-catheter and posterior-to-catheter)
Number of subjects: 53
Study: 24237100

Group type: EXPERIMENTAL
Intervention: Chiropractic care including spinal manipulative therapy and massage
Number of subjects: 52
Study: 20488404

Group type: COMPARATOR
Intervention: Early ISA in BMS
Number of subjects: 1580

Group type: COMPARATOR
Intervention: Early ISA in TAXUS
Number of subjects: 1580

Group type: COMPARATOR
Intervention: Late-acquired ISA in BMS
Number of subjects: 1580

Group type: COMPARATOR
Intervention: Late-acquired ISA in TAXUS
Number of subjects: 1580

Group type: COMPARATOR
Intervention: Late-acquired ISA in TAXUS slow-release
Number of subjects: 1580
Study: 18478575

Group type: EXPERIMENTAL
Intervention: MRI examination
Number of subjects: 23
Study: 16148848

Group type: EXPERIMENTAL
Intervention: RIX4414 (10^4.7 ffu)
Number of subjects: 2155

Group type: EXPERIMENTAL
Intervention: RIX4414 (10^5.2 ffu)
Number of subjects: 2155

Group type: EXPERIMENTAL
Intervention: RIX4414 (10^5.8 ffu)
Number of subjects: 2155

Group type: EXPERIMENTAL
Intervention: RIX4414 (pooled vaccine groups)
Number of subjects: 2155

Group type: EXPERIMENTAL
Intervention: RIX4414 (post-dose 1 to 14 days post-dose 2)
Number of subjects: 2155

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2155
Study: 12548268

Group type: EXPERIMENTAL
Intervention: In-person triage without knowledge of vital signs
Number of subjects: 201

Group type: EXPERIMENTAL
Intervention: In-person triage with knowledge of vital signs
Number of subjects: 201
Study: 11020919

Group type: EXPERIMENTAL
Intervention: Speech therapy with active participation of mothers
Number of subjects: 0

Group type: COMPARATOR
Intervention: Speech therapy without active participation of mothers (control group)
Number of subjects: 0
Study: 8543554

Group type: EXPERIMENTAL
Intervention: Sertraline (mean dose 87 mg/day)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Desipramine (mean dose 110 mg/day)
Number of subjects: 32
Study: 1805284

Group type: EXPERIMENTAL
Intervention: Aspartame chocolate drink (80 mg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sucrose chocolate drink (50 g)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Fasting
Number of subjects: 0
Study: 6139364

Group type: EXPERIMENTAL
Intervention: Triazolam
Number of subjects: 53

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 53
Study: 29313803

Group type: EXPERIMENTAL
Intervention: Doxycycline (3-week course)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 27040594

Group type: COMPARATOR
Intervention: External stent
Number of subjects: 328

Group type: EXPERIMENTAL
Intervention: Internal stent
Number of subjects: 328
Study: 25187345

Group type: EXPERIMENTAL
Intervention: Radiofrequency (RF) turbinoplasty
Number of subjects: 90

Group type: COMPARATOR
Intervention: Partial resection of the middle turbinate
Number of subjects: 90

Group type: COMPARATOR
Intervention: Medialization of the middle turbinate by scarification to the septum
Number of subjects: 90
Study: 23789288

Group type: EXPERIMENTAL
Intervention: Intravenous omega-3 polyunsaturated fatty acids infusion
Number of subjects: 40

Group type: COMPARATOR
Intervention: 0.9% saline solution infusion (Control)
Number of subjects: 40
Study: 21368667

Group type: EXPERIMENTAL
Intervention: Leech therapy (2 to 4 locally applied leeches)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Topical diclofenac (30-day course)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Leech therapy
Number of subjects: 40

Group type: COMPARATOR
Intervention: Topical diclofenac
Number of subjects: 40
Study: 17659263

Group type: EXPERIMENTAL
Intervention: 2 g of sarcosine daily
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: 1 g of sarcosine daily
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Both doses of sarcosine
Number of subjects: 20
Study: 16608764

Group type: EXPERIMENTAL
Intervention: Dynamic resistance training for 13 weeks (free-weight squat lift, concentric phase performed explosively)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (no resistance training)
Number of subjects: 30
Study: 10969521

Group type: EXPERIMENTAL
Intervention: i.v. tramadol (1 mg/kg)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (no tramadol)
Number of subjects: 40
Study: 8851611

Group type: EXPERIMENTAL
Intervention: Cefetamet pivoxil (500 mg)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Cefuroxime axetil (125 mg and 250 mg)
Number of subjects: 27
Study: 1519960

Group type: EXPERIMENTAL
Intervention: Ready-to-feed infant formula
Number of subjects: 43

Group type: COMPARATOR
Intervention: Powdered infant formula
Number of subjects: 43

Group type: COMPARATOR
Intervention: Breast fed infants
Number of subjects: 43
Study: 6380356

Group type: EXPERIMENTAL
Intervention: Theophylline (therapeutic serum concentration averaged 13 mg/L, range 4.0 to 22.1)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study: 30148969

Group type: EXPERIMENTAL
Intervention: 15% of 1-repetition maximum (1RM) without BFR (15/00)
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: 15% 1RM with BFR at 40% of arterial occlusion pressure (AOP) (15/40)
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: 15% of 1RM with BFR at 80% of AOP (15/80)
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: 70% of 1RM without BFR (70/00)
Number of subjects: 97
Study: 30160510

Group type: EXPERIMENTAL
Intervention: Targeted Training in Illness Management (TTIM)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 0
Study: 27401638

Group type: EXPERIMENTAL
Intervention: Intensive lipid-lowering treatment (ezetimibe/simvastatin 10/40 mg, n=34)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Control statin treatment (pravastatin 20 mg, n=36)
Number of subjects: 70
Study: 24169031

Group type: EXPERIMENTAL
Intervention: Beauty treatments during hospitalization
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group (no beauty treatments)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Sense of Coherence (SOC) assessment
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Younger age
Number of subjects: 100
Study: 22161082

Group type: EXPERIMENTAL
Intervention: Ramosetron (n = 60)
Number of subjects: 119

Group type: COMPARATOR
Intervention: No prophylaxis (Control group, n = 59)
Number of subjects: 119
Study: 20303051

Group type: EXPERIMENTAL
Intervention: Zekrya burs
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Er:YAG laser (1.8 W, 450 mJ, 4 Hz, 113 J/cm²)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Direct Nd:YAG laser irradiation (2.0 W, 100 mJ, 20 Hz, 124 J/cm²)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Indirect Nd:YAG laser irradiation
Number of subjects: 40
Study: 18340366

Group type: EXPERIMENTAL
Intervention: Tramadol (2 mg/kg)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Dexamethasone (8 mg)
Number of subjects: 60
Study: 15709665

Group type: EXPERIMENTAL
Intervention: Automatic contour detection algorithm for indicator dilution videodensitometry
Number of subjects: 0

Group type: COMPARATOR
Intervention: Manual contour definition
Number of subjects: 0
Study: 12700955

Group type: EXPERIMENTAL
Intervention: Felodipine ER 5 mg once daily
Number of subjects: 133

Group type: COMPARATOR
Intervention: Felodipine ER 2.5 mg once daily
Number of subjects: 133

Group type: COMPARATOR
Intervention: Felodipine ER 10 mg once daily
Number of subjects: 133

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 133
Study: 10355807

Group type: EXPERIMENTAL
Intervention: Sequential neuromotor examination at 3, 6, and 12 months
Number of subjects: 157

Group type: EXPERIMENTAL
Intervention: Sequential neuromotor examination at 12 months
Number of subjects: 157

Group type: EXPERIMENTAL
Intervention: Sequential neuromotor examination
Number of subjects: 157

Group type: EXPERIMENTAL
Intervention: Positive neonatal urine drug screen for both cocaine and opiates
Number of subjects: 157

Group type: EXPERIMENTAL
Intervention: Positive maternal drug screens for concurrent cocaine and opiate use
Number of subjects: 157
Study: 8918563

Group type: EXPERIMENTAL
Intervention: Oral prednisolone (starting dose 100 mg/day for 20 weeks)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Intravenous immunoglobulin (1 g/kg body weight for 2 consecutive days every 3 weeks, repeated six times)
Number of subjects: 19
Study: 1927090

Group type: EXPERIMENTAL
Intervention: Cremaster muscle resection
Number of subjects: 390

Group type: COMPARATOR
Intervention: No cremaster muscle resection
Number of subjects: 390
Study: 31203776

Group type: EXPERIMENTAL
Intervention: Listening to music and watching video games during blood draw
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified what intervention was used)
Number of subjects: 0